Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 700,846 | 647,819 | 590,232 | 797,520 | 1,085,222 |
| Cost of Goods | 496,964 | 464,958 | 437,503 | 532,652 | 665,271 |
| Gross Profit | 203,882 | 182,861 | 152,729 | 264,868 | 419,951 |
| Operating Expenses | 86,224 | 73,851 | 65,781 | 104,450 | 73,691 |
| Operating Income | 118,622 | 109,968 | 87,451 | 161,070 | 346,531 |
| Interest Expense | 13,328 | 10,734 | 11,572 | 12,380 | 10,600 |
| Pre-tax Income | 105,294 | 99,234 | 75,879 | 148,690 | 335,931 |
| Income Tax | 25,447 | 18,249 | 10,855 | 33,758 | 77,305 |
| Net Income Continuous | 79,847 | 80,985 | 65,024 | 114,932 | 258,626 |
| Net Income Discontinuous | -58 | 2,111 | -1,165 | N/A | N/A |
| Minority Interests | 263 | -29 | -36 | 85 | 1,141 |
| Net Income | $79,526 | $83,125 | $63,895 | $114,847 | $257,485 |
| EPS Basic Total Ops | 1.80 | 1.88 | 1.47 | 2.69 | 5.80 |
| EPS Basic Continuous Ops | 1.81 | 1.83 | 1.50 | 2.69 | 5.83 |
| EPS Basic Discontinuous Ops | -0.01 | 0.05 | -0.03 | N/A | N/A |
| EPS Diluted Total Ops | 1.79 | 1.88 | 1.46 | 2.68 | 5.77 |
| EPS Diluted Continuous Ops | 1.80 | 1.83 | 1.49 | 2.68 | 5.80 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.05 | -0.03 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 2.28 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $141,709 | $134,492 | $114,323 | $188,527 | $373,227 |